logo
Madras HC says right to privacy is not absolute; Tamil Nadu government is required to prevent social harm

Madras HC says right to privacy is not absolute; Tamil Nadu government is required to prevent social harm

Mint2 days ago

In a significant ruling, the Madras High Court on Tuesday said the Right to Privacy is not absolute and the Tamil Nadu governmentis required to prevent social harm.
The court was hearing petitions challenging the Tamil Nadu Online Gaming Authority (Real Money Games) Regulations 2025, mandating a 'blank hour' midnight to 5 AM ban on gaming and an Aadhaar-based user verification system.
A Madras High Court bench of justices SM Subramaniam and K Rajasekar dismissed the petitions, saying that the online gaming regulations amounted to 'reasonable restrictions' that govern all fundamental rights.
The bench added that a user's fundamental right to privacy cannot be considered absolute and needs to be balanced with public interest.
'When put on a scale, public interest overweighs the right to privacy,' it said.
The court reserved its order on 30 April, saying the Tamil Nadu government can 'step in' if online real-money games are addictive and cause social harm, reported Hindustan Times.
Senior counsel Mukul Rohatgi and Sajjan Poovayya, representing gaming companies, opposed the regulations, saying that the Union government already regulated such games.
They also argued that the Tamil Nadu government was trying to indirectly prohibit online gaming under the guise of protecting users from addiction.
Digital gaming platforms such as Play Games 24x7, Head Digital Works, and Junglee Games India, opposed provisions prohibiting users under 18 from playing real-money games, 'know your customer' registration with Aadhaar for opening gaming accounts, and ban on playing during 'blank hours'.
Defending the online gaming regulations, the Tamil Nadu government said that users often included minors and that addiction was ruining their health.
The latest Madras High Court judgement will reinforce the Tamil Nadu government's authority to regulate online gaming and would also empower other states to implement similar regulatory measures to safeguard health and well-being of users.

Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

How Medikabazaar's new CEO is trying to turn around the business, target profitability this year
How Medikabazaar's new CEO is trying to turn around the business, target profitability this year

Mint

time13 minutes ago

  • Mint

How Medikabazaar's new CEO is trying to turn around the business, target profitability this year

Medikabazaar, the medical equipment supplier, expects to put the controversies surrounding the startup behind it as it targets profitability this year, CEO Dinesh Lodha told Mint in an exclusive interview. The startup, which is entangled in legal disputes, has started exports and is expanding its portfolio offerings to drive growth. Lodha, who was appointed group CEO in August 2024, said the business is turning around and that will help rebuild confidence among its investors and customers. 'This is the third quarter going on, [since] I joined, and in the last two quarters there are significant changes happening in the business. We have cut down our loss by 80% by quarter four from quarter one," he told Mint. 'In Q4 we ended up at a revenue run rate of ₹2,200 crore, with some losses. Next year, we're looking at a run rate of ₹3,200 crore by Q4FY26, with Ebitda profitability. For the first time the company will show a solid profitability and a good cash flow." Lodha said his mandate is to run the business and that the dispute between investors is not a distraction. 'The team is very focused. And my approach is also very focused," said Lodha. 'The way things are getting turned around, I think people are getting more and more confident. We are not losing customers because of this." The Mumbai-based B2B medical supply chain platform has been mired in controversy and legal disputes following a whistleblower complaint in December 2023 accusing the then-senior management of round-tripping of accounts to inflate revenue and other irregularities. The allegations have been validated by forensic audits. The company's auditor resigned, its FY23 financials were restated, and its leadership was overhauled. Founder's ouster Co-founder Vivek Tiwari stepped down as chief executive officer in July 2024 to take on a board role. He was then ousted by the company's board in April 2025 over allegations of malicious and fraudulent activities, including financial mismanagement and financial fraud. Tiwari is fighting cases in multiple jurisdictions, including the Delhi High Court and the National Company Law Tribunal. In an earlier interview to Mint, he denied allegations of financial misreporting. Also Read | Medikabazaar's ousted CEO denies board's allegations of financial irregularities Additionally, the company's Series C investors including Creagis, CDC Group, HealthQuad and Ackermans & van Haaren, filed an indemnity claim, or compensation, of ₹279 crore against the company over allegations of financial misreporting. Lodha comes with over two decades of experience in the healthcare and medtech space, having previously worked as group CEO at Healthium Medtech, country head for Samsung's healthcare vertical, and sales director at GE Healthcare. He has 'a proven track record of leading successful turnarounds of businesses," according to his LinkedIn profile. Medikabazaar reported a gross operating revenue of ₹1,355.5 crore in FY24, a 50% surge from the preceding year, according to Entrackr. Its loss widened by 30% to ₹394.8 crore. The company's expansion is driven by adding new growth segments and an internal clean-up with a focus on transparency. 'If you ask me one word in this organisation which I've tried to change, it is to 'empower' the people to take decisions, but then be accountable," he said. The company has had a good retention of its leadership, employees and customers over the past 18 months, Lodha said. 'That itself gives you confidence that things are pretty much solid in place," Lodha said. 'We have added many new segments, new leaders. But we retain the core," he added. Exports to drive growth Lodha is driving the company's expansion beyond Indian shores. The company is already facilitating Indian manufacturers with certification to export to countries in the Middle East, Africa, some parts of Asia, and South America. 'It is in the early stages… but it is a huge, significant growth area for us as we go forward. At this point of time, export [segment] is not that significant. We are talking 5-6% of our business. But that will significantly grow to 15-20% as we go forward," Lodha said. Also Read | The fallout of an audit and missed targets: Medikabazaar founders set to lose stock options Medikabazaar is a B2B seller for medical equipment and drugs, including consumables such as surgical gloves, devices like MRI machines, and vaccines. It has over 400,000 customers through its digital marketplace and has tied up with over 1,000 hospitals in the country. The company has also started its own brand called MB+ for medical consumables, pharmaceuticals, and vaccines that it will directly offer to customers, which is a high-margin business and will form a significant chunk of the company's revenue, said Lodha. It is targeting tier-2 and tier-3 hospitals and aims to offer complete supply chain and procurement solutions to at least 100-150 hospitals in the next 12-14 months. 'In India, nobody has the portfolio breadth that we have with presence in equipment and devices, consumables, disposables, IVD (in vitro diagnostics) and pharma," said Lodha. 'We offer a one-stop solution in all procurement segments… that's a very big opportunity for hospitals to really work with one company as a single-window procurement partner rather than working with, say, 200 distributors." Medikabazaar competes with large manufacturers in individual segments such as medical equipment companies Wipro GE Healthcare and Medtronic, as well as other B2B marketplaces MedDeal and Zoplar. Also Read | Indian medtech's just coming of age, and already has global ambitions Medikabazaar has raised $165 million (about ₹1,380 crore) via debt and equity to date. It was reportedly in talks to raise $150-200 million last year, which did not materialise after the forensic audit. Lodha said that the company is not looking at raising funds currently and that it built a good cash flow in Q4. 'We are continuing to be focused on cash flow," he said. 'Wherever the investment is required, I think the existing investors [are] very bullish on the business… they are ready to fund it further."

Consecration of 'Raja Ram' to be held at Ram Temple in Ayodhya
Consecration of 'Raja Ram' to be held at Ram Temple in Ayodhya

The Hindu

time15 minutes ago

  • The Hindu

Consecration of 'Raja Ram' to be held at Ram Temple in Ayodhya

The consecration of 'Raja Ram' — Lord Rama in his king form — will take place on the first floor of the grand Ram Temple in Ayodhya on Thursday (June 5, 2025), coinciding with the occasion of Ganga Dussehra. This is the second consecration ceremony at the temple. The first consecration ceremony was that of the Ram Lalla idol at the temple complex on January 22, 2024 in the presence of Prime Minister Narendra Modi. Speaking to PTI, Mahant Raghuvar Sharan, the chief priest of Rasik Niwas Temple in Ayodhya, said, "This year, Ganga Dussehra will not only be sacred but also historic, as after a long struggle of 500 years, Lord Ram, known as 'Rajarama', will be ceremonially installed on the first floor of the grand Ram Temple in Ayodhya. The occasion will witness a unique blend of enthusiasm, devotion, and spirituality in Ayodhya." The consecration ceremony will be held between 11:25 a.m. and 11:40 a.m., Ram Temple trustee Anil Mishra said. According to Hindu scriptures, Ganga Dussehra marks the day the holy river Ganga descended to Earth from Lord Shiva's locks, moved by King Bhagirath's penance. The day is considered highly auspicious and symbolises virtue, penance, and the collective well-being of humanity. Ayodhya-based astrologer Pandit Kalki Ram said any auspicious deed performed on Ganga Dussehra yields manifold results. "Perhaps this is why the Ram Temple Trust chose this day for the consecration of Rajarama," he said. In addition to the main Ram Darbar, the consecration of eight other temples within the Ram Temple complex will also take place on Thursday (June 5, 2025). Mr. Mishra said the ceremonies will be conducted with full religious rituals and Vedic chants, and learned Brahmins from across the country will participate in the event. "The day of Ganga Dussehra will symbolise a new beginning. It will be the moment when the fruits of centuries of penance, struggle, and faith will manifest in tangible form," Mr. Mishra added. Uttar Pradesh Chief Minister Yogi Adityanath also took to social media to announce the consecration ceremony. "Today, in the holy birthplace of Lord Shri Ram, Ayodhya Dham, we are getting the great fortune of becoming a witness to the program organised for the Pran-Pratishtha of the holy idols of gods in the eight temples including Shri Ram Darbar on the first floor of Shri Ram Janmabhoomi Temple," he posted on X in Hindi. प्रभु श्री राम की पावन जन्मभूमि अयोध्या धाम में आज श्री राम जन्मभूमि मंदिर के प्रथम तल पर श्री राम दरबार सहित अष्ट देवालयों में पवित्र देव विग्रहों की प्राण-प्रतिष्ठा हेतु आयोजित कार्यक्रम का साक्षी बनने का परम सौभाग्य प्राप्त हो रहा है। यह पावन अवसर 'एक भारत-श्रेष्ठ भारत' की… — Yogi Adityanath (@myogiadityanath) June 5, 2025 "This auspicious occasion is a new expression of 'Ek Bharat-Shrestha Bharat'. Victory to Siyavar Shri Ramachandra!" he added.

Supreme Court refuses to intervene in Madras High Court order on consecration rites in Tiruchendur temple
Supreme Court refuses to intervene in Madras High Court order on consecration rites in Tiruchendur temple

The Hindu

time15 minutes ago

  • The Hindu

Supreme Court refuses to intervene in Madras High Court order on consecration rites in Tiruchendur temple

The Supreme Court on Wednesday (June 4, 2025) refused to intervene in a plea against a Madras High Court order constituting a committee to fix the schedule for Kumbhabhishekam (consecration ceremony) for Arulmigu Subramaniya Swamy Temple in Tiruchendur, Tamil Nadu. A Bench headed by Justice P. K. Mishra however allowed the petitioner, R. Sivarama Subramaniya Sasthrigal, the Vidhayahar at the temple, to file a review plea against the High Court order. The Madurai Bench of the Madras High Court had directed the constitution of a committee of experts to decide the timing for conducting the consecration ceremony at the temple. The petitioner, in the High Court, had argued that he said he had been the Vidhayahar at the temple for the past 13 years. During temple festivals and other functions he had to fix the timings for their commencement, pujas and celebrations and point out customary and Agamic practices and principles to be adopted according to the nature of the deities and the functions, he had said in the High Court. He had argued in the High Court that the date (July 7) and the timing fixed for the ceremony were not suitable for the event. The petitioner had sought a direction to the authorities to follow the ancient texts and literature and declare the consecration ceremony.

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into the world of global news and events? Download our app today from your preferred app store and start exploring.
app-storeplay-store